Showing results (241-250 of 1,098) with videos related to
Sort By:
Pageof 110
Clinical Chemistry and Laboratory Medicine|July 26, 2018
The global impact of the International Federation of Clinical Chemistry and Laboratory Medicine, Education and Management Division: engaging stakeholders and assessing HbA1c quality in a multicentre study across ChinaEmma English, Cas Weykamp, Linong Ji, et al.Clinical Medicine Insights. Cardiology|May 7, 2013
Unique and Varied Contributions of Traditional CVD Risk Factors: A Systematic Literature Review of CAD Risk Factors in ChinaJoanne Foody, Yong Huo, Linong Ji, et al.Nature Medicine|May 25, 2023
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trialLeili Gao, Byung Wan Lee, Manoj Chawla, et al.Plos One|February 13, 2015
ACEI/ARB underused in patients with type 2 diabetes in Chinese population (CCMR-3B study)Qionghong Xie, Chuan-Ming Hao, Linong Ji, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 21, 2025
Real-World Effectiveness of Insulin Glargine 300 U/ml in People with Type 2 Diabetes Previously Treated with Tirzepatide: The DELIVER-T StudyRobert Ritzel, Melanie J Davies, Lichen Hao, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 22, 2021
A Pragmatic Study of Basal and Mid-Mixture Insulins as Starter Insulins in Chinese Patients With Type 2 Diabetes: Observations From Long-Term, Real-World ExperienceTianshu Zeng, Huijuan Yuan, Jiangong Ren, et al.Endocrine|August 14, 2014
Effect of GLP-1 receptor agonists on waist circumference among type 2 diabetes patients: a systematic review and network meta-analysisFeng Sun, Shanshan Wu, Shuxia Guo, et al.Diabetes, Obesity & Metabolism|March 10, 2026
Integrated Plasma Proteomics and Functional Analyses Reveal Hepatic CDHR2 as a Potential Therapeutic Target in MASLDYuanping Shi, Qi Huang, Yingning Liu, et al.Scientific Reports|November 3, 2016
Interactive effect of serum uric acid and total bilirubin for cardiovascular disease in Chinese patients with type 2 diabetesYanfeng Ren, Nan Jin, Tianpei Hong, et al.Diabetes Technology & Therapeutics|January 19, 2017
Lipohypertrophy in China: Prevalence, Risk Factors, Insulin Consumption, and Clinical ImpactLinong Ji, Zilin Sun, Qifu Li, et al.Pageof 110